Suriasis SA to Present at Medtech Insight's ``Investment In Innovation'' EUROPE Conference.GENEVA -- Suriasis SA has announced that it will be presenting at September 20, 2:20 PM (CET CET abbr. Central European Time CET Central European Time CET n abbr (= Central European Time) → hora de Europa central CET abbr ) at Medtech Insight's "Investment In Innovation (In3) EUROPE: A Preview of Early-Stage Medical Technology Companies" Conference, taking place September 20-21, 2005 at The Crowne Plaza This article or section needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. Brussels City Centre Hotel in Brussels, Belgium. Suriasis SA, a provider of surface modification technologies to the healthcare industry, is presenting a major revolution in bone-to-implant integration -- SurfLink(TM) -- that 'naturally glues' the human tissue to an implant and acts as a 'bone healing promoter.' At the In3 conference, Dr. Bjorn-Owe Aronsson, Founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will give the investor community a presentation of the company and its planed growth strategies. Triply awarded by McKinsey for its business plan and strategy, Suriasis recently received the Swiss CTI (Computer Telephone Integration) Combining data with voice systems in order to enhance telephone services. For example, automatic number identification (ANI) allows a caller's records to be retrieved from the database while the call is routed to the appropriate party. Start-Up Label, which is an official acknowledgement that the company is ready for 'sustainable growth.' In a venture industry panel's ranking of the Top Swiss Ventures, the company was ranked number two of the Newcomers. This acknowledgement comes when Suriasis is starting its first financial round, where it counts on raising about USD USD In currencies, this is the abbreviation for the U.S. Dollar. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 2.3 Million. About SurfLink(TM): SurfLink(TM) is a chemical compound that can be used as a surface treatment for dental and orthopedic implants. SurfLink(TM) is a by the market requested technology that finally becomes available, solving a medical problem and a so far unmet need. Since the late 90-ies implant manufacturers try to develop technologies to decrease the healing time and to avoid / minimize risks associated with the implants. These risks include insufficient fixation which results in bad functioning, displacement or loosening of the implant, pain, and, finally, the need for implant replacement. Recently conducted pre-clinical studies on SurfLink(TM) confirmed the in-vitro results. Compared to current state-of-the art technologies SurfLink(TM) has a much better bone anchorage and produces significantly higher amounts of bone proteins. As a result, the patients' benefits of SurfLink(TM) are: --much faster (two fold) healing time, reducing medical costs and pain; --significantly increased long-term stability; --strongly reduced risk for dislodgment dislodgment, n the movement or removal of a prosthesis from its established position. of the implant, especially critical for non-fusion spinal implants. Suriasis provides a chemical interface for bone anchored implants and prosthesis prosthesis (prŏs`thĭsĭs): see artificial limb. prosthesis Artificial substitute for a missing part of the body, usually an arm or leg. resulting in better integration and more predictable restoration results. The company is capitalizing on the unique combination of experience spanning from fundamental surface physics to applied medicine. About Suriasis SA: Suriasis SA, a spin-off of the University of Geneva The University of Geneva (Université de Genève) is a university in Geneva, Switzerland. It was founded by John Calvin in 1559. Initially a theological seminary, it also taught law. and EPFL EPFL Ecole Polytechnique Fédérale de Lausanne (French: Swiss Federal Institute of Technology, Lausanne, Switzerland) EPFL Enoch Pratt Free Library (Baltimore, Maryland) EPFL European Professional Football Leagues , Lausanne, has its headquarters in Geneva, Switzerland and is extensively collaborating with dental and orthopedic professionals, university-based scientists as well as with several leading implant manufacturers. For more information please contact: Bjorn-Owe Aronsson at +41.22.884 83 45 or bjorn-owe.aronsson@suriasis.com or visit our website www.suriasis.com. Medtech Insight, a division of Windhover wind·hov·er n. Chiefly British A kestrel. Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. To register for the "Investment In Innovation EUROPE" conference or for more information on Medtech Insight, please call Kristy Grimes at 480-985-9512, e-mail kristy@medtechinsight.com, or visit www.medtechinsight.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion